The introduction of the ACUVUE OASYS MAX 1-Day Multifocal for Astigmatism represents a significant shift in the landscape of corrective ocular health within the United Kingdom and Ireland. Officially rolled out by Johnson & Johnson on 04 February 2026, this specific lens is engineered as the first and only daily disposable multifocal toric contact lens specifically designed for astigmatic presbyopes. This demographic represents a substantial portion of the population, as astigmatism is estimated to affect approximately half of all patients in at least one eye. Furthermore, the global trend of an ageing population suggests that by the year 2030, up to 2.1 billion people worldwide will develop presbyopia, the age-related loss of near-focusing ability. The ACUVUE OASYS MAX 1-Day Multifocal for Astigmatism addresses this complex intersection of visual impairments—simultaneous astigmatism and presbyopia—through built-in personalisation and the application of Eye Inspired Innovations.
The trial process for these lenses is not merely a matter of distribution but a structured clinical pathway designed to maximise first-visit success. According to data provided by Johnson & Johnson, nearly 91% of wearers were successfully fit in their first pair of lenses during their initial visit. This high success rate is attributed to a combination of digital precision via the Simplifit calculator and physical demonstration via the Flipper tool. For the consumer and the patient, this means a reduction in the traditional "trial and error" phase often associated with multifocal toric lenses, leading to faster stabilisation of vision and higher patient satisfaction.
The Clinical Trial Pathway and Fitting Process
The transition to ACUVUE OASYS MAX 1-Day Multifocal for Astigmatism follows a rigorous five-step logic to ensure that the patient receives the most accurate prescription from the outset. This process is designed to eliminate the guesswork that historically plagued practitioners who relied on outdated paper fitting guides or subjective personal experience, both of which were prone to inconsistencies.
The process begins with the use of the ACUVUE Simplifit Calculator. This digital resource is a critical component of the trial because it combines both astigmatism and multifocal calculations into a single interface. This provides a reliable, up-to-date point of reference that allows the Eye Care Professional (ECP) to identify the initial lens prescription required for the patient. Beyond the initial prescription, the calculator is used to determine recommended enhancements. If a patient indicates that further improvement is needed for either distance vision or near vision, the Simplifit tool provides the specific adjustments needed to optimise the visual outcome.
Once the calculations are finalised, the Eye Care Professional orders the trial lenses to the practice. Because these lenses are custom-fit to the patient's specific astigmatism and presbyopia requirements, they are typically fitted during a follow-up visit. However, for patients who are eager to experience the benefits immediately at the first appointment, Johnson & Johnson has introduced a bridge between the calculation and the arrival of the lenses: the Flipper demonstration tool.
The ACUVUE Astigmatism Demonstration Flipper
The Flipper demonstration tool is a physical innovation designed to overcome the limitations of traditional trial lens kits. A standard trial kit typically only covers approximately 25% of the prescription range, which can leave patients in the dark regarding the potential benefits of the lens if their specific power is not in stock. The flipper solves this by allowing the practitioner to simulate the effect of astigmatism correction in real time.
The tool functions by incorporating cylinder power and allowing the practitioner to rotate the lenses to align with different axes. This is particularly useful for showing existing ACUVUE multifocal wearers who have not yet corrected their cylinder—up to -1.75D—what their vision could look like with full correction.
The physical operation of the flipper is highly specific to ensure clinical accuracy:
- The side of the tool without the axis markings must be held towards the patient's face.
- For a monocular astigmat (astigmatism in only one eye), the side not required is flipped up into a 90-degree position.
- For patients requiring astigmatism correction in both eyes, both sides are positioned down.
- The practitioner uses handles on the blue lens holders to rotate the pre-installed lens or lenses to the desired axis position.
Once positioned, the patient is asked to look at distance objects, near objects, or specific test types. This allows for a direct, subjective comparison between their current vision and the vision they can expect once their ACUVUE OASYS MAX 1-Day Multifocal for Astigmatism trial lenses arrive. This direct visual evidence is considered more impactful than a verbal explanation of the benefits.
Technical Specifications and Proprietary Technologies
The ACUVUE OASYS MAX 1-Day family is built upon a foundation of several proprietary technologies designed to maintain ocular comfort and visual clarity. These technologies are essential for the success of the trial, as the patient's subjective comfort determines whether they will continue with the product.
| Technology | Primary Function | Clinical Impact |
|---|---|---|
| TearStable™ Technology | Stabilization of the tear film | Increases visual tear break up time (TBUT) |
| Pupil Optimized Design | Light management and pupil alignment | Reduction of visual artifacts and improved contrast |
| Eye Inspired Innovations | Personalisation of lens geometry | Higher first-visit fitting success rate (91%) |
| Multifocal Toric Design | Dual correction of presbyopia and astigmatism | Elimination of the need for separate reading glasses |
A key performance metric for the ACUVUE OASYS MAX 1-Day is its effect on the tear film. Data indicates that more wearers achieved a visual tear break up time of 10 seconds or more when compared to the standard ACUVUE OASYS 1-Day. This suggests a more stable hydration layer on the eye, which is critical for multifocal lenses where dryness can often lead to blurred vision or "ghosting."
It is important to note that the lenses include HEV light filtering; however, it has not been demonstrated that this filtering confers any systemic or ocular health benefits to the user. This is a technical specification that practitioners must communicate to patients to manage expectations.
Trial Lens Management and Tool Storage
To ensure that the Flipper demonstration tool remains an integrated part of the clinical workflow, Johnson & Johnson has provided a specific system for storing the tool alongside the trial lens kits. This ensures that the ECP does not lose the tool and can find it immediately when a new patient arrives for a fitting.
The storage process involves a series of precise steps:
- The tool comes with a sleeve and hook and loop fasteners.
- The user must take the part of the fastener attached to the sleeve and peel off the adhesive backing.
- The fastener is then stuck onto the desired part of the ACUVUE OASYS MAX 1-Day MULTIFOCAL kit.
- Recommended placement is on the side of the kit; if the side is unavailable, it may be placed on top, provided it does not cover the label.
- The fastener is pressed firmly to ensure a permanent bond.
- Finally, the sleeve is pressed onto the fastener on the kit, ensuring full contact along the entire length for a secure attachment.
This organised approach to tool storage mirrors the organised approach to the fitting process, ensuring that the digital calculator, the physical flipper, and the trial lenses work in a cohesive sequence.
Comparison of Trial Experiences
The shift from traditional fitting methods to the ACUVUE OASYS MAX 1-Day system represents a move from subjective estimation to data-driven precision.
- Traditional Method: Practitioners often relied on paper guides or personal experience. This led to a higher incidence of follow-up appointments to "tweak" the prescription and a lower first-visit success rate.
- Modern Method: The integration of the Simplifit Calculator and the Flipper tool provides a single, reliable point of reference. The patient sees the result immediately via the flipper, and the practitioner uses a digital tool to ensure the trial lens ordered is the most accurate possible.
For the patient, the impact is a reduction in the time spent wearing suboptimal lenses. For the practitioner, it reduces the administrative and clinical burden of multiple fitting appointments.
Analysis of Patient Suitability and Outcomes
The target audience for this trial is broad but specific. It encompasses both new multifocal contact lens wearers and existing wearers who have not yet addressed their astigmatism.
For new wearers, the trial serves as an introduction to a complex lens type. The high initial success rate (91%) is crucial here, as a poor first experience with multifocal lenses often leads to patient dropout. By using the flipper to set expectations and the Simplifit calculator to ensure accuracy, the barrier to entry is lowered.
For existing multifocal wearers, the trial is often an upgrade. Many patients tolerate a small amount of uncorrected astigmatism (up to -1.75D of cylinder) but find that their vision is not "crisp." The flipper tool is specifically used in these cases to demonstrate the difference that cylinder correction makes. Once the patient sees the clarity provided by the flipper, the motivation to switch to the ACUVUE OASYS MAX 1-Day Multifocal for Astigmatism increases significantly.
The ultimate outcome of this trial process is the delivery of a lens that manages the ocular surface better (via TearStable™ Technology) and provides a more tailored visual experience. While some wearers may still require later lens modification—as indicated by the study of 171 participants—the overall trend is toward a more streamlined, efficient, and successful fitting process.